Efficacy and Safety of Brolucizumab for Diabetic Macular Edema

Дата публикации: 01-12-2023 00:00:00

This randomized clinical trial evaluates the efficacy and safety of brolucizumab vs aflibercept dosed every 4 weeks in participants with diabetic macular edema.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Sterile Intraocular Inflammation Associated With Faricimab	0	9.17	01-11-2024
2	Detecting Glaucoma in Myopic Eyes With OCT	0	7	02-07-2026
3	Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia	0	13.66	01-06-2024
4	Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US	0	15.59	01-12-2024
5	Diabetic Retinopathy and Quality of Life	0	8.72	01-03-2024
6	Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy	0	7.7	01-08-2024
7	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026
8	Erucamide molecule strengthens the eye's response to damage in retinal disease	2	7	22-06-2026
9	Efficacy and Safety of Mazdutide for Type 2 Diabetes: a GRADE assessed systematic review and meta-analysis of randomized controlled trials [version 1; peer review: awaiting peer review]	0	8.78	06-08-2026
10	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer	0	5	18-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.97. Источник: jamanetwork.com.